Glioma
Table of Contents
2018| January-February | Volume 1 | Issue 1
Please wait, loading Google Map...
| EDITORIAL | ||
| Preface from Editor-in-Chief | p. 1 | |
| Zhong-Ping Chen | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| REVIEWS |  |
|
 |
Myeloid-derived suppressor cells and nonresolving inflammatory cells in glioma microenvironment: molecular mechanisms and therapeutic strategies | p. 2 |
| Xiao-Yan Ji, Jia-Wei Ma, Jun Dong | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
 |
Current concepts of imaging genomics in glioma | p. 9 |
| Ru-Jia Wang, Gui-Quan Shen, Mark S Shiroishi, Bo Gao | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| ORIGINAL ARTICLES | |
|
 |
Vasculogenic mimicry persists during glioblastoma xenograft growth | p. 16 |
| Cong Li, Yin-Sheng Chen, Qing-Ping Zhang, Jian-Liang Chen, Jing Wang, Fu-Rong Chen, Ho-Keung N G, Zhong-Ping Chen | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
 |
In vitro therapy against glioblastoma cells by 3-Dezaneplanocin-A, panobinostat, and temozolomide | p. 22 |
| Javier de la Rosa, Alejandro Urdiciain, Bárbara Meléndez, Juan A Rey, Miguel A Idoate, Javier S Castresana | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
 |
Be cautious to bid farewell to GBMO: evidence from a propensity score analysis | p. 27 |
| Haihui Jiang, Yong Cui, Xiaohui Ren, Song Lin | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||